Cell Line : PE-CA-PJ15
Cellosaurus Index : CVCL_2678
Cellosaurus ID : PE-CA-PJ15
CCLE Name
: PECAPJ15_UPPER_AERODIGESTIVE_TRACT
CTRP2 Name
: PECAPJ15
GDSC1 Name
, GDSC2 Name
: PE-CA-PJ15
Cancer Type : upper_aerodigestive_tract
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| PE-CA-PJ15 | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | 3-Cl-AHPC | CTRP2 | 0.0041 | 66.0000 |
|
| PE-CA-PJ15 | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| PE-CA-PJ15 | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | AA-COCF3 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | ABT737 | GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| PE-CA-PJ15 | AGK-2 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| PE-CA-PJ15 | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| PE-CA-PJ15 | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | Alpelisib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| PE-CA-PJ15 | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| PE-CA-PJ15 | AS605240 | GDSC1 | 0.0400 | 20.0000 |
|
| PE-CA-PJ15 | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| PE-CA-PJ15 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AT7867 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| PE-CA-PJ15 | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | avrainvillamide | CTRP2 | 0.0020 | 33.0000 |
|
| PE-CA-PJ15 | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| PE-CA-PJ15 | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD1480 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| PE-CA-PJ15 | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| PE-CA-PJ15 | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | AZD6482 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| PE-CA-PJ15 | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD8055 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| PE-CA-PJ15 | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| PE-CA-PJ15 | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| PE-CA-PJ15 | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| PE-CA-PJ15 | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| PE-CA-PJ15 | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Belinostat | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BI-2536 | GDSC2,CTRP2 | 0.0005 | 33.0000 |
|
| PE-CA-PJ15 | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| PE-CA-PJ15 | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| PE-CA-PJ15 | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| PE-CA-PJ15 | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BMS-536924 | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Bortezomib | GDSC2,CTRP2 | 0.0000 | 0.1300 |
|
| PE-CA-PJ15 | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| PE-CA-PJ15 | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| PE-CA-PJ15 | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| PE-CA-PJ15 | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K50799972 | CTRP2 | 0.0020 | 17.0000 |
|
| PE-CA-PJ15 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K55116708 | CTRP2 | 0.0020 | 17.0000 |
|
| PE-CA-PJ15 | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| PE-CA-PJ15 | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| PE-CA-PJ15 | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| PE-CA-PJ15 | BRD55319 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| PE-CA-PJ15 | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| PE-CA-PJ15 | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| PE-CA-PJ15 | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| PE-CA-PJ15 | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| PE-CA-PJ15 | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| PE-CA-PJ15 | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| PE-CA-PJ15 | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | CD-437 | CTRP2 | 0.0011 | 18.0000 |
|
| PE-CA-PJ15 | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | Cediranib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| PE-CA-PJ15 | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| PE-CA-PJ15 | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | CHIR-99021 | GDSC1,GDSC2,CTRP2 | 0.0024 | 80.0000 |
|
| PE-CA-PJ15 | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| PE-CA-PJ15 | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| PE-CA-PJ15 | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | COL-3 | CTRP2 | 0.0020 | 17.0000 |
|
| PE-CA-PJ15 | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| PE-CA-PJ15 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Crizotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| PE-CA-PJ15 | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| PE-CA-PJ15 | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Dabrafenib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| PE-CA-PJ15 | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| PE-CA-PJ15 | Dactolisib | GDSC1,GDSC2,CTRP2 | 0.0003 | 17.0000 |
|
| PE-CA-PJ15 | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0001 | 2.0000 |
|
| PE-CA-PJ15 | Dasatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Dinaciclib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| PE-CA-PJ15 | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| PE-CA-PJ15 | Docetaxel | GDSC1,GDSC2,CTRP2 | 0.0000 | 66.0000 |
|
| PE-CA-PJ15 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| PE-CA-PJ15 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| PE-CA-PJ15 | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Enzastaurin | GDSC1 | 0.0400 | 20.0000 |
|
| PE-CA-PJ15 | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| PE-CA-PJ15 | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| PE-CA-PJ15 | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Erlotinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| PE-CA-PJ15 | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| PE-CA-PJ15 | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Fedratinib | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| PE-CA-PJ15 | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| PE-CA-PJ15 | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | FMK | GDSC1 | 0.0400 | 20.0000 |
|
| PE-CA-PJ15 | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| PE-CA-PJ15 | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| PE-CA-PJ15 | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| PE-CA-PJ15 | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| PE-CA-PJ15 | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Gemcitabine | GDSC1,GDSC2,CTRP2 | 0.0002 | 33.0000 |
|
| PE-CA-PJ15 | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| PE-CA-PJ15 | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| PE-CA-PJ15 | GSK1059615 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | GSK1070916 | GDSC1 | 0.0100 | 10.2400 |
|
| PE-CA-PJ15 | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| PE-CA-PJ15 | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | GSK269962A | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| PE-CA-PJ15 | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | GSK429286A | GDSC1 | 0.0400 | 20.0000 |
|
| PE-CA-PJ15 | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| PE-CA-PJ15 | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | Ibrutinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| PE-CA-PJ15 | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| PE-CA-PJ15 | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PE-CA-PJ15 | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| PE-CA-PJ15 | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| PE-CA-PJ15 | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| PE-CA-PJ15 | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 25.0000 |
|
| PE-CA-PJ15 | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0039 | 66.0000 |
|
| PE-CA-PJ15 | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| PE-CA-PJ15 | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| PE-CA-PJ15 | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | L-685458 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | Lapatinib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| PE-CA-PJ15 | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| PE-CA-PJ15 | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| PE-CA-PJ15 | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| PE-CA-PJ15 | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| PE-CA-PJ15 | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| PE-CA-PJ15 | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | MG-132 | GDSC2,CTRP2 | 0.0006 | 20.0000 |
|
| PE-CA-PJ15 | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| PE-CA-PJ15 | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| PE-CA-PJ15 | MIRA-1 | GDSC2,CTRP2 | 0.0020 | 17.0000 |
|
| PE-CA-PJ15 | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| PE-CA-PJ15 | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | ML203 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| PE-CA-PJ15 | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| PE-CA-PJ15 | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| PE-CA-PJ15 | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| PE-CA-PJ15 | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Navitoclax | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| PE-CA-PJ15 | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| PE-CA-PJ15 | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| PE-CA-PJ15 | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| PE-CA-PJ15 | Nutlin-3a | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| PE-CA-PJ15 | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | NVP-TAE684 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Obatoclax Mesylate | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Olaparib | GDSC1,GDSC2,CTRP2 | 0.0045 | 150.0000 |
|
| PE-CA-PJ15 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| PE-CA-PJ15 | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| PE-CA-PJ15 | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | Oxaliplatin | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | PAC-1 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Paclitaxel | GDSC2,CTRP2 | 0.0001 | 66.0000 |
|
| PE-CA-PJ15 | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| PE-CA-PJ15 | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| PE-CA-PJ15 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| PE-CA-PJ15 | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| PE-CA-PJ15 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| PE-CA-PJ15 | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| PE-CA-PJ15 | Pevonedistat | GDSC1,GDSC2,CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| PE-CA-PJ15 | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| PE-CA-PJ15 | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| PE-CA-PJ15 | PI-103 | GDSC1,CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| PE-CA-PJ15 | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Piperlongumine | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| PE-CA-PJ15 | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | PLX-4720 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| PE-CA-PJ15 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| PE-CA-PJ15 | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| PE-CA-PJ15 | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| PE-CA-PJ15 | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| PE-CA-PJ15 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | R428 | CTRP2 | 0.0020 | 33.0000 |
|
| PE-CA-PJ15 | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | RAF265 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Rapamycin | GDSC2,CTRP2 | 0.0001 | 33.0000 |
|
| PE-CA-PJ15 | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| PE-CA-PJ15 | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| PE-CA-PJ15 | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| PE-CA-PJ15 | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| PE-CA-PJ15 | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | Saracatinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| PE-CA-PJ15 | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| PE-CA-PJ15 | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| PE-CA-PJ15 | Selumetinib | GDSC1,GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| PE-CA-PJ15 | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PE-CA-PJ15 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PE-CA-PJ15 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PE-CA-PJ15 | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| PE-CA-PJ15 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PE-CA-PJ15 | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PE-CA-PJ15 | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PE-CA-PJ15 | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PE-CA-PJ15 | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| PE-CA-PJ15 | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 83.0000 |
|
| PE-CA-PJ15 | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| PE-CA-PJ15 | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| PE-CA-PJ15 | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| PE-CA-PJ15 | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| PE-CA-PJ15 | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PE-CA-PJ15 | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | SN-38 | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| PE-CA-PJ15 | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | SNX-2112 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PE-CA-PJ15 | Sorafenib | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| PE-CA-PJ15 | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | T-5345967 | CTRP2 | 0.0160 | 530.0000 |
|
| PE-CA-PJ15 | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| PE-CA-PJ15 | TAK-715 | GDSC1 | 0.0400 | 20.0000 |
|
| PE-CA-PJ15 | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| PE-CA-PJ15 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Tanespimycin | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| PE-CA-PJ15 | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Telomerase Inhibitor IX | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0041 | 66.0000 |
|
| PE-CA-PJ15 | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| PE-CA-PJ15 | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| PE-CA-PJ15 | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| PE-CA-PJ15 | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| PE-CA-PJ15 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Tivozanib | GDSC1,CTRP2 | 0.0004 | 13.0000 |
|
| PE-CA-PJ15 | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | TL-2-105 | GDSC1 | 0.0200 | 10.2400 |
|
| PE-CA-PJ15 | Topotecan | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | tosedostat | CTRP2 | 0.0160 | 270.0000 |
|
| PE-CA-PJ15 | Tozasertib | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Trametinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| PE-CA-PJ15 | Tretinoin | GDSC1,GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| PE-CA-PJ15 | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| PE-CA-PJ15 | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| PE-CA-PJ15 | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| PE-CA-PJ15 | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | TW 37 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | UNC0638 | GDSC1,CTRP2 | 0.0010 | 40.0000 |
|
| PE-CA-PJ15 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| PE-CA-PJ15 | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| PE-CA-PJ15 | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| PE-CA-PJ15 | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| PE-CA-PJ15 | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| PE-CA-PJ15 | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| PE-CA-PJ15 | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| PE-CA-PJ15 | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| PE-CA-PJ15 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| PE-CA-PJ15 | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| PE-CA-PJ15 | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Vorinostat | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| PE-CA-PJ15 | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| PE-CA-PJ15 | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| PE-CA-PJ15 | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| PE-CA-PJ15 | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| PE-CA-PJ15 | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| PE-CA-PJ15 | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| PE-CA-PJ15 | YL54 | CTRP2 | 0.0020 | 33.0000 |
|
| PE-CA-PJ15 | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| PE-CA-PJ15 | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| PE-CA-PJ15 | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| PE-CA-PJ15 | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| PE-CA-PJ15 | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| PE-CA-PJ15 | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC